Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
100 results. Finviz
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company Name

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

DM
2026-11-16
ANROAlto Neuroscience, Inc.Hanley Jr. Michael ConickCOOS - Sale+OE$27.61-75,0000-100%-$2,070,389
D
2026-11-16
CYTKCytokinetics IncBlum Robert IPres, CEOS - Sale+OE$53.53-7,500282,710-3%-$401,460
2026-11-16
SEPNSepterna, Inc.Labrucherie Gil MCFOS - Sale$41.62-20,00027,002-43%-$832,359
2026-11-18
BIVIBiovie Inc.Do Cuong VPres, CEOP - Purchase$1.00+2,50021,117+13%+$2,493
D
2026-11-17
CYTKCytokinetics IncMalik Fady IbrahamEVP Research, DevelopmentS - Sale+OE$51.78-3,500153,902-2%-$181,227
M
2026-11-16
ANABAnaptysbio, IncEcor1 Capital, LLCDir, 10%P - Purchase$45.98+374,5808,254,674+5%+$17,224,593
2026-11-17
CYTKCytokinetics IncHessekiel JeffreyChief Legal, Admin OfficerS - Sale$52.62-15,10692,837-14%-$794,878
M
2026-11-16
ROIVRoivant Sciences Ltd.Manchester Keith SDirS - Sale$38.75-1,381,76219,304,554-7%-$53,536,738
M
2026-11-16
ROIVRoivant Sciences Ltd.Gold Daniel AllenDirS - Sale$38.75-1,381,76219,304,554-7%-$53,536,738
2026-11-16
EWTXEdgewise Therapeutics, Inc.Donovan Joanne M.CMOS - Sale$45.48-8548,139-9%-$38,840
M
2026-11-16
ROIVRoivant Sciences Ltd.Qvt Financial LPDirector by DeputizationS - Sale$38.75-1,381,76219,304,554-7%-$53,536,738
2026-11-16
CRMDCormedix Inc.Kaplan MyronDirP - Purchase$4.88+25,000286,487+10%+$122,000
D
2026-11-16
PTCTPtc Therapeutics, Inc.Boulding Mark ElliottEVP, CLOS - Sale+OE$61.88-2,812105,272-3%-$174,013
D
2026-11-17
RYTMRhythm Pharmaceuticals, Inc.Jean ChristopheDirS - Sale+OE$109.66-10,00011,712-46%-$1,096,550
D
2026-11-17
UTHRUnited Therapeutics CorpRothblatt Martine ACHAIRPERSON, CEOS - Sale+OE$580.43-9,500668,728-1%-$5,514,046
D
2026-11-17
ASNDAscendis Pharma A/SPedersen Anni Lotte Kirstine SonderbjergEVP, Chief Admin OfficerS - Sale+OE$263.89-20,00019,460-51%-$5,277,720
2026-11-16
LRMRLarimar Therapeutics, Inc.Clayton RussellChief Medical OfficerP - Purchase$3.01+3,32274,765+5%+$9,999
2026-11-16
VRTXVertex Pharmaceuticals Inc / MaThornberry NancyDirS - Sale$547.86-1,0001,109-47%-$547,860
2026-11-16
VRTXVertex Pharmaceuticals Inc / MaBhatia Sangeeta N.DirS - Sale$547.86-2714,653-6%-$148,470
2026-11-17
RPRXRoyalty Pharma PlcHite ChristopherEVP, COB, PartneringS - Sale$68.15-100,000200,723-33%-$6,814,710
M
2026-11-16
RPRXRoyalty Pharma PlcCoyne Terrance P.EVP, CFOS - Sale$68.81-257,12250,390-84%-$17,693,642
2026-11-16
RPRXRoyalty Pharma PlcUrist MarshallEVP, Research, InvestmentsS - Sale$69.50-25,000149,361-14%-$1,737,490
M
2026-11-16
REGNRegeneron Pharmaceuticals, Inc.Sing George LDirS - Sale$958.97-2,00025,297-7%-$1,917,945
D
2026-11-16
ARQTArcutis Biotherapeutics, Inc.Welgus Howard G.DirS - Sale+OE$28.16-4,72834,573-12%-$133,140
2026-11-16
FLNAFilana Therapeutics, Inc.Barry RichardPres, CEOP - Purchase$0.47+440,2061,778,170+33%+$206,897
D
2026-11-16
AMPHAmphastar Pharmaceuticals, Inc.Peters William JCFO, EVP, TreasurerS - Sale+OE$29.99-11,000167,076-6%-$329,890
2026-11-16
FLNAFilana Therapeutics, Inc.Schoen EricCFOP - Purchase$0.42+20,00031,500+174%+$8,400
2026-11-16
REGNRegeneron Pharmaceuticals, Inc.McCourt MarionEVP CommercialS - Sale$960.26-56610,524-5%-$543,504
2026-11-18
ALTAltimmune, Inc.Menziuso Richard ThomasPrincipal Accounting OfficerP - Purchase$1.42+10,00010,000New+$14,187
D
2026-11-17
REGNRegeneron Pharmaceuticals, Inc.Murphy Andrew JCo-Chief Scientific OfficerS - Sale+OE$957.76-5,01151,193-9%-$4,799,336
2026-11-16
FLNAFilana Therapeutics, Inc.Cook Robert ChristopherCOO,Legal OfficerP - Purchase$0.46+121,575135,300+886%+$55,925
2026-11-16
KURAKura Oncology, Inc.Doyle Thomas JamesSVP, Finance, AccountingS - Sale$7.44-4,697138,581-3%-$34,946
M
2026-11-16
KURAKura Oncology, Inc.Leoni MollieChief Medical OfficerS - Sale$7.45-41,25099,845-29%-$307,122
M
2026-11-16
KURAKura Oncology, Inc.Powl Brian T.Chief Commercial OfficerS - Sale$7.45-24,450113,265-18%-$182,061
2026-11-16
KURAKura Oncology, Inc.Bair Teresa BrophyGCS - Sale$7.44-8,601178,401-5%-$63,991
M
2026-11-16
KURAKura Oncology, Inc.Ford KathleenCOOS - Sale$7.45-10,710132,276-7%-$79,756
2026-11-16
IRWDIronwood Pharmaceuticals IncGaskins Tammi LChief Commercial OfficerS - Sale$4.81-5,919344,431-2%-$28,470
D
2026-11-18
ZYMEZymeworks Inc.Platshon ScottEVP, Chief Business OfficerS - Sale+OE$24.95-15,29221,745-41%-$381,535
2026-11-17
CATXPerspective Therapeutics, Inc.Williamson Robert F IIIDirP - Purchase$0.84+25,000168,744+17%+$20,950
M
2026-11-16
BOLTBolt Biotherapeutics, Inc.Coastlands Capital LP10%P - Purchase$5.84+53,094515,510+11%+$309,922
M
2026-11-13
KTTAPasithea Therapeutics Corp.Coastlands Capital LP10%P - Purchase$0.48+1,667,5145,502,549+43%+$805,944
2026-11-16
PTGXProtagonist Therapeutics, IncMolina Arturo MdChief Medical OfficerS - Sale$124.65-2,71881,397-3%-$338,799
M
2026-11-13
BOLDBoundless Bio, Inc.Tang Kevin10%P - Purchase$2.40+13,8123,049,3790%+$33,149
2026-11-13
RCKTRocket Pharmaceuticals, Inc.Shah GauravCEOS - Sale$2.25-3,0201,459,8120%-$6,795
2026-11-13
RCKTRocket Pharmaceuticals, Inc.Wilson MartinGCS - Sale$2.25-4,087541,013-1%-$9,196
D
2026-11-16
MIRMMirum Pharmaceuticals, Inc.Ramasastry SairaDirS - Sale+OE$92.28-2,0000-100%-$184,560
D
2026-11-16
UTHRUnited Therapeutics CorpRothblatt Martine ACHAIRPERSON, CEOS - Sale+OE$587.74-9,500668,728-1%-$5,583,501
2026-11-13
BBOTBridgebio Oncology Therapeutics, Inc.Cobo MarcPrincipal Accounting OfficerS - Sale$2.37-7813,734-1%-$185
2026-11-13
CORTCorcept Therapeutics IncWilson James NDirS - Sale$72.67-10,0001,444,543-1%-$726,678
D
2026-11-16
MCRBSeres Therapeutics, Inc.Brady KellySee RemarksS - Sale+OE$1.38-858,775-1%-$117
D
2026-11-16
MCRBSeres Therapeutics, Inc.Desrosier ThomasSee RemarksS - Sale+OE$1.38-1038,258-1%-$142
D
2026-11-16
MCRBSeres Therapeutics, Inc.Shaff Eric D.DirS - Sale+OE$1.38-28712,936-2%-$396
D
2026-11-16
MCRBSeres Therapeutics, Inc.Henn Matthew RSee RemarksS - Sale+OE$1.38-1018,132-1%-$139
2026-11-13
PEPGPepgen Inc.Ra Capital Management, L.P.Dir, 10%P - Purchase$5.00+8,625,00028,689,545+43%+$43,125,000
M
2026-11-13
MAIAMaia Biotechnology, Inc.Smith StanDirP - Purchase$1.00+100,0001,632,918+7%+$100,000
M
2026-11-13
MAIAMaia Biotechnology, Inc.Vitoc VladCEO, 10%P - Purchase$1.00+100,0001,359,221+8%+$100,000
AM
2026-11-13
KURAKura Oncology, Inc.Wilson Troy EdwardPres, CEOP - Purchase$7.52+200,0001,414,650+16%+$1,504,765
2026-11-16
CATXPerspective Therapeutics, Inc.Morich FrankDirP - Purchase$0.94+15,00030,000+100%+$14,046
M
2026-11-13
KURAKura Oncology, Inc.Wilson Troy EdwardPres, CEOP - Purchase$7.52+200,0001,414,650+16%+$1,504,765
2026-11-12
BLTEBelite Bio, IncScholl Hendrik PeterChief Medical OfficerS - Sale$165.99-2,00012,500-14%-$331,976
D
2026-11-12
SEPNSepterna, Inc.Finer JeffreyCEOS - Sale+OE$43.62-18,500833,909-2%-$807,015
D
2026-11-16
ORKAOruka Therapeutics, Inc.Goncalves JoanaChief Medical OfficerS - Sale+OE$100.96-7,00031,771-18%-$706,700
D
2026-11-13
UTHRUnited Therapeutics CorpRothblatt Martine ACHAIRPERSON, CEOS - Sale+OE$592.42-9,500668,728-1%-$5,627,991
2026-11-12
VRTXVertex Pharmaceuticals Inc / MaWagner Charles F JrEVP, CO, FOS - Sale$547.87-15,28631,764-32%-$8,374,741
2026-11-13
BIVIBiovie Inc.Do Cuong VPres, CEOP - Purchase$1.16+2,50018,617+16%+$2,906
2026-11-16
GERNGeron CorpWilliams TimothyEVP, GCP - Purchase$0.94+12,00012,000New+$11,280
2026-11-13
GERNGeron CorpSemerjian HaroutPres, CEOP - Purchase$0.95+53,50053,500New+$50,825
2026-11-13
AUPHAurinia Pharmaceuticals Inc.Robertson Stephen P.GCS - Sale$15.97-11,867576,981-2%-$189,516
2026-11-12
LGNDLigand Pharmaceuticals IncKozarich John WDirS - Sale$325.00-50042,122-1%-$162,500
M
2026-11-04
CVSICv Sciences, Inc.Cheever Charlie E III10%P - Purchase$0.01+5,440,92632,089,637+20%+$54,409
D
2026-11-12
MRKMerck & Co., Inc.Deluca Richard R.EVP, Pres, Merck Animal HealltS - Sale+OE$148.01-58,185114,291-34%-$8,611,875
2026-11-12
LGNDLigand Pharmaceuticals IncZimmermann MartineDirS - Sale$318.17-2,0001,782-53%-$636,336
2026-11-13
DYNDyne Therapeutics, Inc.Lucera ErickCFOS - Sale$16.82-1,991117,775-2%-$33,489
2026-11-12
LFVNLifevantage CorpBeindorff Michael ADirS - Sale$4.89-10,00082,709-11%-$48,861
M
2026-11-12
PHIOPhio Pharmaceuticals Corp.Deming David HDirP - Purchase$0.82+12,00061,800+24%+$9,823
2026-11-12
CTTHCtt Pharmaceutical Holdings, Inc.Ctt Pharmaceutical Holdings, Inc.CEOP - Purchase$0.05+1,5009,454,0360%+$81
2026-11-12
CATXPerspective Therapeutics, Inc.Morich FrankDirP - Purchase$1.00+15,00015,000New+$14,957
2026-11-12
CATXPerspective Therapeutics, Inc.Williamson Robert F IIIDirP - Purchase$0.84+24,898143,744+21%+$20,906
2026-11-12
CATXPerspective Therapeutics, Inc.Woods Lori ADirP - Purchase$0.84+23,750212,017+13%+$20,040
2026-11-13
ABEOAbeona Therapeutics Inc.Charles Faith L.DirP - Purchase$2.29+15,000191,407+9%+$34,349
2026-11-13
CRMDCormedix Inc.Todisco JosephCEOP - Purchase$4.89+80,000854,749+10%+$391,200
D
2026-11-13
ZYMEZymeworks Inc.Moore Paul AndrewChief Scientific OfficerS - Sale+OE$26.07-39,74133,756-54%-$1,035,961
D
2026-11-12
ORKAOruka Therapeutics, Inc.Agarwal ArjunSVP, FinanceS - Sale+OE$104.97-10,00014,219-41%-$1,049,658
D
2026-11-12
ORKAOruka Therapeutics, Inc.Ball Kristine MDirS - Sale+OE$104.93-18,0000-100%-$1,888,749
2026-11-11
PBYIPuma Biotechnology, Inc.Miller Michael PatrickDirS - Sale$8.10-15,00066,000-19%-$121,457
2026-11-11
SEPNSepterna, Inc.Ezekowitz AlanDirS - Sale$48.09-81,82035,600-70%-$3,934,363
D
2026-11-11
TNGXTango Therapeutics, Inc.Crystal AdamPres, R, DS - Sale+OE$25.00-5,000115,743-4%-$125,000
M
2026-11-11
CRVSCorvus Pharmaceuticals, Inc.Arcara JeffreyChief Business OfficerP - Purchase$11.22+4,5004,500New+$50,475
2026-11-10
ZLABZai Lab LtdGaynor RichardDirP - Purchase$27.19+1,22881,965+2%+$33,389
2026-11-11
MANEVeradermics, IncEnright Patrick GDirS - Sale$150.38-500,0001,803,474-22%-$75,190,000
2026-11-11
MANEVeradermics, IncLongitude Capital Partners V, LLC10%S - Sale$150.38-500,0001,803,474-22%-$75,190,000
2026-11-13
NTHINeonc Technologies Holdings, Inc.Heshmatpour Amir FCEO, Pres, 10%P - Purchase$5.02+30,0007,873,1400%+$150,501
M
2026-11-11
KRROKorro Bio, Inc.Formela Jean FrancoisDirS - Sale$14.61-66,632121,219-35%-$973,609
D
2026-11-11
MIRMMirum Pharmaceuticals, Inc.Brege LauraDirS - Sale+OE$94.21-14,16715,703-47%-$1,334,656
D
2026-11-12
JNJJohnson & JohnsonForminard ElizabethEVP, GCS - Sale+OE$284.39-13,07216,994-43%-$3,717,546
2026-11-13
ANIPAni Pharmaceuticals IncCook MeredithSVP, GC, SEC.S - Sale$70.80-50072,924-1%-$35,400
D
2026-11-12
UTHRUnited Therapeutics CorpRothblatt Martine ACHAIRPERSON, CEOS - Sale+OE$593.52-9,500668,728-1%-$5,638,445
2026-11-11
ALDXAldeyra Therapeutics, Inc.Alfieri MichaelPrincipal Financial OfficerP - Purchase$0.65+10,00017,500+133%+$6,500
D
2026-11-10
CORTCorcept Therapeutics IncSwisher Daniel N JrDirS - Sale+OE$74.07-1,5000-100%-$111,105
2026-11-13
ALTAltimmune, Inc.Weaver Gregory LCFOP - Purchase$1.62+10,00073,005+16%+$16,200

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top